塞费皮姆延长输液的临床结果
Aaron Shaykevich1, Renee Kirchgraber2, Ivayla Geneva3
1Crouse Hospital, Syracuse, NY; Department of Public Health and Preventative Medicine, SUNY Upstate, Syracuse, NY.
延长输液塞菲皮姆 (EI cefepime) 对某些感染有希望,与标准输液相比,可能会改善结果. 需要进一步的研究来证实其在不同患者群体中的益处和安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 塞菲皮姆是第四代塞法洛斯波林,通常以标准的30分钟输液形式给予.
- 长时间输液 (3-4小时) 可能会提高药理动力学目标的实现.
研究的目的:
- 审查延长输液塞费皮姆 (EI cefepime) 在各种感染和患者群体中的临床影响.
- 与标准输液相比,评估证据,以改善结果和安全性.
主要方法:
- 现有文献的叙述性审查.
- 对EI cefepime有效性和安全性的回顾性和前性研究的分析.
主要成果:
- 追溯数据表明,在某些特定群体 (如 Pseudomonas aeruginosa 感染或发烧性中性病症) 中,结果有所改善 (例如,死亡率降低,发酵速度更快).
- 前性试验并未始终显示出显著的死亡率降低益处.
- 潜在的风险,如神经毒性,需要进一步调查,特别是在成年人.
结论:
- 延长输液Cefepime与标准输液无差,在某些临床场景中可能具有优势.
- 进一步的前性,受控试验对于在不同患者群体中建立EI cefepime的最终有效性和安全性概况至关重要.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
相关概念视频
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acute Pyelonephritis II: Diagnostic Studies and Management
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Urine Studies II: Urine Culture and Sensitivity Test
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
